Presentation Information

[P2-05-3]Genetic risks of common side effects following COVID-19 booster vaccination in a cohort of corporate employees in Japan

Yosuke Omae1,2, Seik-Soon Khor1, Mihoko Shimada1, Yosuke Kawai1, Taihei Yamaguchi2, Maiko Yagi2, Masashi Ebisawa2, Junko Takeuchi3, Tetsuya Mizoue3, Wataru Sugiura3, Katsushi Tokunaga1 (1.Genome Medical Science Project, National Institute of Global Health and Medicine, Japan Institute for Health Security, 2.Life Science Business Office, Corporate Technology Planning Division, Toshiba Corporation, Tokyo, Japan, 3.Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan)

Password required to view